Invite-Only Working Session: Disease Prevention and Emergency Response

Home

Working Session #3 Disease Prevention and Emergency Response

We are excited to announce that the third Working Session of the Public Health Track of the Social Impact Initiative will be held on Friday, November 13. The working session format will be an interactive discussion around disease prevention and control in China, vaccines, and emergency response. AmCham China is inviting international experts, policy makers, industry leaders, and other key stakeholders to attend and contribute to an interactive discussion. Working session participants will develop actionable policy recommendations in these topics geared towards policymakers in China.

Participation in the Working Session

Please note that attendance for the working session is invite-only. We will be using an online conference system that allows online attendees to speak/participate in the session. Through this system, participants can also select whether to listen to the discussion in English or Chinese language.

Also, if you have registered for the working session but cannot attend or plan to bring guests, please let the Social Impact Initiative team know at least 48 hoursin advance since we will organize small group discussions and make other arrangements based on the final attendee list.

Case Studies

AmCham China would like to supplement the Working Session content and material with case studies led and presented by our member companies. We are looking for 2 to 3 sponsoring members that are willing to present during the Working Session. This is an opportunity to present your company's real-word experience and share best practices/lessons learned with working session participants. Case study presentations will (1) present/identify the problem, (2) discuss the steps that were taken to address the problem, and (3) identify lessons learned and how they apply to the topic at hand. If you are interested in presenting a case study, please contact Kathy Li (kli@amchamchina.org).

Note: The agenda on the event page is a working agenda and subject to change before the actual working session.

Agenda

9:00 AM - 9:10 AM

Welcome and Introductions

9:10 AM - 9:20 AM

Setting the Stage: Introduction to Disease Prevention and Control in China

9:20 AM - 9:30 AM

Discussion on Disease Prevention Efforts in China

9:30 AM - 10:20 AM

Discussion Topic #1: Vaccines

10:20 AM - 10:50 AM

Coffee Break

10:50 AM - 11:40 AM

Discussion Topic #2: Emergency Response Systems

11:40 AM - 11:55 AM

Summarizing the Discussion: Recommendations and Conclusions

11:55 AM - 12:00 PM

Wrap Up: Next Steps

Sponsors and Partners

Organizer

View website

Platinum Sponsors

Merck
Merck, a leading science and technology company, operates across Healthcare, Life Science and Performance Materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries.

Merck has been in China for 87 years, In 1933, Merck founded E. Merck Chemical Co., Ltd., its first subsidiary in Shanghai. China is one of the most strategically important countries for Merck and has become a global center of innovation for Merck. Merck’s Healthcare in Nantong, Life Science in Nantong and Performance Materials in Shanghai have investments of 170 million Euros, 80 million Euros, and 44 million Euros respectively. Merck China has nearly 4,100 employees and 20 legal entities operate in Beijing, Shanghai, Hong Kong, Wuxi, Suzhou and Nantong.
www.merckgroup.com/cn-zh
view more

Gold Sponsors

Dell (China) Co., Ltd. Beijing Office
Dell Technologies is committed to transforming businesses, shaping the future of innovation and developing technologies to drive human progress.
www.dell.com/learn/cn/zh/cncorp1/corp-comm
view more
Honeywell
Honeywell is a Fortune 500 technology company that delivers industry specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help everything from aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable.
Honeywell’s long history in China goes back to 1935 when it established its first franchise in Shanghai. As of today, and all of Honeywell’s strategic business groups are substantially present in the country, with Shanghai serving as the company’s Asia Pacific headquarters. Honeywell has over 50 wholly owned enterprises and joint ventures in more than 30 cities across the country, including 20 plus manufacturing sites. Honeywell now employs about 11,000 people in China, among which about 20% are scientists and engineers.
www.honeywell.com.cn/
view more

Advisors

Invite-Only Working Session: Disease Prevention and Emergency Response

Social Impact Initiative Public Health Working Session#3

Invite-Only Working Session: Disease Prevention and Emergency Response

Social Impact Initiative Public Health Working Session#3

Home

Agenda

Merck

Dell (China) Co., Ltd. Beijing Office

Honeywell